Basal Cell Nevus Syndrome
Information
- Disease name
- Basal Cell Nevus Syndrome
- Disease ID
- Description
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
| Genes | Mutation | Description | Source | Links |
|---|
| NCT ID | Status | Phase | Summary | Start date | Completion date |
|---|---|---|---|---|---|
| NCT03467789 | Active, not recruiting | Phase 1 | Vitamin D as a Nutritional Neoadjuvant During Photodynamic Therapy of Basal Cell Carcinoma | October 1, 2018 | September 1, 2024 |
| NCT00957229 | Completed | Phase 2 | To Determine The Efficacy and Safety of GDC-0449 in Patients With Basal Cell Nevus Syndrome (BCNS) | August 2009 | January 2014 |
| NCT01556009 | Completed | Phase 2 | Trial Comparing the Effects of Intermittent Vismodegib vs. PDT in Patients With Multiple Basal Cell Carcinomas | April 2012 | December 2015 |
| NCT02100371 | Completed | N/A | Study of BMS-833923 in Two Specific Patients With Basal Cell Nevus Syndrome | February 2014 | May 2017 |
| NCT02157623 | Completed | N/A | Blue vs Red Light During Levulan Based Photodynamic Therapy in Patients With Basal Cell Nevus Syndrome | February 1, 2016 | December 1, 2016 |
| NCT02550678 | Completed | Phase 1/Phase 2 | A Study of the Efficacy and Safety of ASN-002 in Adult Patients With Low-risk Nodular Basal Cell Carcinoma | September 2015 | November 2017 |
| NCT02762084 | Completed | Phase 2 | Trial of Patidegib Gel 2%, 4%, and Vehicle to Decrease the Number of Surgically Eligible Basal Cell Carcinomas in Gorlin Syndrome Patients | June 6, 2016 | April 24, 2017 |
| NCT00555633 | Completed | Use of an SPF30 Sunscreen and an After-sun-lotion in Skin Cancer Risk Patients | October 2004 | February 2006 | |
| NCT03703310 | Completed | Phase 3 | Study of Patidegib Topical Gel, 2%, for the Reduction of Disease Burden of Persistently Developing Basal Cell Carcinomas (BCCs) in Subjects With Basal Cell Nevus Syndrome (Gorlin Syndrome) | February 19, 2019 | December 28, 2020 |
| NCT04416516 | Completed | Phase 2 | Safety and Efficacy of ASN-002 Combined With a Hedgehog Pathway Inhibitor | July 16, 2020 | February 14, 2024 |
| NCT06330324 | Enrolling by invitation | Reproductive Options in Inherited Skin Diseases | January 1, 2024 | September 1, 2026 | |
| NCT06330350 | Recruiting | Qualitative Study in Patients With Genodermatoses and Healthcare Professionals on Reproductive Counselling | January 1, 2024 | December 31, 2025 | |
| NCT05463757 | Recruiting | Oral Hedgehog Inhibitors in the Treatment of Basal Cell Carcinoma in the Netherlands: a Prospective Registration Study | November 1, 2021 | December 2024 | |
| NCT04308395 | Terminated | Phase 3 | Extension Study of Patidegib Topical Gel, 2% in Subjects With Gorlin Syndrome (Basal Cell Nevus Syndrome) | June 3, 2020 | July 14, 2021 |
| NCT02303041 | Terminated | Phase 2 | Pilot Study of Sonidegib and Buparlisib in Treating Patients With Advanced or Metastatic Basal Cell Carcinoma | February 2015 | June 2017 |
| NCT03767439 | Withdrawn | Phase 2 | Nivolumab With Vismodegib in Patients With Basal Cell Nevus Syndrome | July 2019 | February 2020 |
- MeSH unique ID (MeSH (Medical Subject Headings))
- D001478